


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.32%
-0.16%
+10.67%
+2.29%
+3.09%
ABUS
Arbutus Biopharma
$4.06
ABUS Price Performance
$4.43 (-8.35%)
$4.28 (-5.14%)
$3.65 (+11.23%)
$3.36 (+20.83%)
ABUS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

ABUS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ABUS Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABUS Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is ABUS current stock price?
What are ABUS stock strengths?
What is ABUS Risk Level?
What is ABUS market cap and volume?
What is ABUS current Stock IQ?
Should I buy ABUS stock right now?
Is ABUS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ABUS?
What does a 'Strong Sell' rating mean for ABUS?
What factors influence ABUS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.32%
-0.16%
+10.67%
+2.29%
+3.09%
ABUS
Arbutus Biopharma
Current Price
$4.06
ABUS Stock IQ
Stock Insights
Not Enough Information

ABUS Price Performance
$4.43 (-8.35%)
$4.28 (-5.14%)
$3.65 (+11.23%)
$3.36 (+20.83%)
ABUS Analysts Opinion
ABUS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
ABUS Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ABUS Street Sentiment is bullish and have negative views on the near-term outlook
ABUS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Average key support and resistance price levels
ABUS Latest Analysis
Arbutus Biopharma Shares Fall 19% On European Patent Revocation . (RTTNews) - Arbutus Biopharma Corp. (ABUS) saw its stock tumble after the European Patent Office (EPO) revoked one of its key lipid nanoparticle (LNP) patents EP2279254 after years of opposition proceedings initiated by Moderna and Merck affiliates.
Fri Jan 16, 2026
Arbutus (ABUS) Upgraded to Buy: Heres What You Should Know. Arbutus (ABUS) has been upgraded to a Zacks Rank #2 (Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ABUS Stock trends
ABUS Stock performance
ABUS Stock analysis
ABUS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.